- Home
- AMPY vs PRQR Comparison
AMPY vs PRQR Comparison
Compare AMPY & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | PRQR |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 250.7M |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AMPY | PRQR |
|---|---|---|
| Price | $4.87 | $2.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $11.00 | $8.14 |
| AVG Volume (30 Days) | ★ 690.9K | 558.5K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $275,827,100.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.27 | $1.07 |
| 52 Week High | $6.62 | $3.46 |
Technical Indicators
Market Signals| Indicator | AMPY | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 53.75 |
| Support Level | $5.17 | $2.15 |
| Resistance Level | $5.90 | $2.42 |
| Average True Range (ATR) | 0.24 | 0.19 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 1.42 | 79.70 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.